CXCL16 and type 2 diabetes mellitus: To further determine whether ANG-1, CXCL16, PDGF-BB, TIMP-1, and VEGFR2 levels were significantly increased in DME, 100 DME patients and 100 T2DM patients were recruited to validate the array data using ELISA.